Benjamin Dutzar

Benjamin Dutzar is a seasoned scientist with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as a Scientist at Cyrus Biotechnology since July 2022, Benjamin previously held roles at Neoleukin Therapeutics and Kineta, Inc. as an Immunology Scientist. In a notable long-term position at Alder Biopharmaceuticals from March 2006 to February 2020, Benjamin ascended from Research Associate II to Associate Director and Head of Molecular Biology, focusing on Antibody Discovery. Additional experience includes a Research Associate role at Targeted Genetics Corporation and Nastech Pharmaceutical. Benjamin earned a Bachelor's degree in Biology from Seattle University in 2000.